Multiple Myeloma (Part 1) - Update on Epidemiology, Diagnostic Criteria, Systemic Treatment and Prognosis
- PMID: 37396092
- PMCID: PMC10310414
- DOI: 10.1055/s-0043-1770149
Multiple Myeloma (Part 1) - Update on Epidemiology, Diagnostic Criteria, Systemic Treatment and Prognosis
Abstract
Multiple myeloma (MM) is a hematological malignancy characterized by unregulated and clonal proliferation of plasma cells in the bone marrow; these cells produce and secrete an anomalous monoclonal immunoglobulin, or a fragment of this, called M protein. The clinical manifestations of MM result from the proliferation of these plasmocytes, the excessive production of monoclonal immunoglobulin and the suppression of normal humoral immunity, leading to hypercalcemia, bone destruction, renal failure, suppression of hematopoiesis and humoral immunity, increasing the risk for the development of infections. The increase in life expectancy of the world population led to a concomitant increase in the prevalence of MM, a pathology that usually affects the elderly population. The aim of this review is to update the reader on epidemiology, diagnostic criteria, differential diagnosis with other monoclonal gammopathies, systemic treatment and prognosis of MM.
Keywords: epidemiology; monoclonal gammopathy of undetermined significance; multiple myeloma; plasmacytoma; prognosis; smoldering multiple myeloma.
Sociedade Brasileira de Ortopedia e Traumatologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).
Conflict of interest statement
Conflito de Interesses Os autores declaram não haver conflitos de interesses.
Figures
References
-
- U.S. Department of Health and Human Services National Institutes of Health. National Cancer Institute. USA.gov [Internet]Rockville: NIH National Cancer Institute; c2022. NCI Dictionary of Cancer Terms; Definition of Multiple Myeloma [cited 2022 Abr 16]. Available from:https://www.cancer.gov/publications/dictionaries/cancer-terms/def/multip...
-
- American Cancer Society [Internet]Atlanta American Cancer Society; c2020. About multiple myeloma [cited 2020 Mar 12]. Available from:https://www.cancer.org/cancer/multiple-myeloma/about/what-is-multiple-my...
-
- American Academy of Orthopaedic Surgeons [Internet]Orthoinfo; c2020. Diseases & Conditions: Multiple Myeloma/Plasmacytoma [cited 2020 Mar 12]. Available from:https://orthoinfo.aaos.org/en/diseases–conditions/multiple-myelomaplasma...
-
- Silva R OP, Brandão K MA, Pinto P VM et al. Mieloma múltiplo: características clínicas e laboratoriais ao diagnóstico e estudo prognóstico. Rev Bras Hematol Hemoter. 2009;31(02):63–68.
-
- Kyle R A, Gertz M A, Witzig T E et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78(01):21–33. - PubMed
LinkOut - more resources
Full Text Sources
